Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells
Yamit Shorer Arbel(Tel Aviv University), Yair Herishanu(Tel Aviv University)
Cited by 15
Related Papers
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study
|Mycoses|2019|80
Characteristics and recognition of early infections in patients treated with commercial anti‐CD19 CAR‐T cells
|European Journal Of Haematology|2021|41